版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
AntiproliferativeactivityofdifferentextractsfromDaphnealtaicaPall.onselectedcancercells
Prof.Dr.MuratKizaibekTraditionalKazakhMedicineResearchInstituteofIliKazakhAutonomousPrefecture,P.R.ChinaAlmatyMay3,2012IntroductionCanceristheworld’ssecondbiggestkilleraftercardiovasculardisease.In2005,7.6millionpeoplediedfromcancer,morethanHIV/AIDS,malariaandtuberculosiscombined.Inaddition,thisnumberisexpectedtoriseto9millionin2015andincreasefurtherto11.5millionin2030(WHO,2007).Clearly,thereisagreatneedtoimprovecurrentcancertherapiesandtosearchfornewtherapies.DatafromStatisticsCanadaThroughouthistory,plantshaveaffordedarichsourceofcompoundsthathavefoundmanyapplicationsinthefieldsofmedicine,pharmacyandbiology.Withinthesphereofcancer,plantshaveplayedanimportantroleasasourceofeffectiveanti-canceragents,anditissignificantthatover60%ofcurrentlyusedanti-canceragentsarederivedinonewayoranotherfromnaturalsources,includingplants,marineorganismsandmicro-organisms(Craggetal.,2005).InIliKazakhAutonomousPrefectureofChina,herbalremediesarefrequentlyusedbyTraditionalKazakhMedicine(TKM)doctorstotreatalargevarietyofdiseases,e.g.,hypertension,cancer,rheumatism,andbonefracture.However,thereislittleinformationabouttheirefficacy.DaphnealtaicaPall.,locallyknownasuwsoyq?orqasq?rjiydek,isadeciduousherboftheThymelaeaceaefamily.ItisendemictothenorthofJungarBasinofXinjiang,China(theTachengandHabaheareas),Altai,ManrakandTarbagataiMountainsofKazakhstanandAltairegionofRussiaaswellasnorthwestMongoliaD.altaicahavelongbeenusedinTKMtotreatesophaguscancer,gastriccancer,tracheitis,commoncold,soarthroat,rheumatism,snakebite,andfortheirantitussiveanddiaphoreticproperties(Xuetal.,2009).ItsmedicinalusewasfirstlyrecordedinaKazakhmedicalclassicShipagerlikBayan,whichwaswrittenbyOteyboydakTleukabylulyin15thcentury(Tleukabyluly,1994).OteyboydakTleukabyluly(1388-?)ShipagerlikBayanTranslation:Prescription4573:addthebarkofDaphneintothemeatbrothandboilthem.Assoonasthebrothcomestoafullboil,removetheresidue,drinkthebrothandeatthemeat.Itcancureasthmaandcough.Atpage420ofthisbook,thereisthefollowingprescription:Althoughmanybenefitsofthisplanthavebeenclaimed,noscientificdatumisavailablesofaraboutitsbiologicalproperties,especiallyitsanticanceractivity.Therefore,thispromptedustoinvestigatetheantiproliferativeactivityofthisplantoncancercells.Forthesepurposes,sixextractswerepreparedandtestedfortheirpotentialantiproliferativepropertieswith3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide(MTT)bioassayondifferentcancercelllines.Toourknowledge,thisisthefirsttimethattheanticanceractivityofD.altaicaisevaluated.MATERIALSANDMETHODSPlantmaterialThebarksofD.altaicawerecollectedfromAltaiMountain,Xinjiang,ChinainJuly2008.TheplantwasidentifiedandauthenticatedbyBahargulKongirkhan,aherbalistattheherbariumofAltayInstituteforDrugControl,Xinjiang,China.Avoucherspecimen(No.050036)wasdepositedatthesameplace.TestedmaterialDriedbarksoftheplant(150g)werechoppedandextractedwith95%EtOHbymacerationfor2weeksinadarkplaceataroomtemperatureof20±2℃.Theprocedurewasrepeatedfortwice.Theextractswerecombined,concentratedunderreducedpressureandfreeze-driedtoyieldtheEtOHextract(DA-Et,12.10g).0.5gofthisextractwaskeptforMTTassayandtherestwassubmittedtoasequentialliquid-liquidextractionwithsolventsofincreasedpolaritytoyieldpetroleumether(DA-Pt,1.7064g),chloroform(DA-Ch,0.6915g),ethylacetate(DA-Ea,1.8237g),n-butanol(DA-Bu,2.5242g)andaqueous(DA-Aq,2.5998g)fractions.Cellculturehumanesophagealsquamouscellcarcinoma(Eca-109)cellsgastriccarcinoma(AGS)cellshepatoma(SMMC-7721)cellscervicalcarcinoma(HeLa)cellsAllcelllineswereculturedat37°Cinahumidifiedatmosphereof5%carbondioxide.CellproliferationassayAllthesamplesweretestedat6.25,12.5,25,50,100μg/mlconcentrations.ThesamplesweredissolvedinDMSOandfurtherdilutedwithcellculturemedium.CellsincubatedwiththesameconcentrationofDMSOwereusedasacontrol.TheDMSOfinalconcentrationwasadjustedto1%ofthetotalvolumeofmediuminalltreatments,includingthecontrol.ForMTTassay,1×105cells/wellwereplatedinto96-wellplates(Nunclon,Denmark)andincubatedfor24hbeforetheadditionofdrugs.After48hofincubationforallcells,20μlofMTT(Sigma,USA)reagent(5mg/ml)inphosphatebufferedsaline(PBS)wasaddedtoeachwell.Theplateswereincubatedat37°Cfor4h.Attheendoftheincubationperiod,themediumwasremovedandpureDMSO(150μl)wasaddedtoeachwell.ThemetabolizedMTTproductwasquantifiedbyreadingtheabsorbanceat490nmonaBeckmanCoulter-AD340(BeckmanCoulter,Fullerton,CA,USA).Resultswereexpressedpercentageofcellviability(%).Allassayswereperformedintriplicate.Themediangrowthinhibitoryconcentrationvalues(IC50)wereusedtocomparetheantiproliferativeactivityofextractsoncancercells.StatisticalanalysisTheresultsofpercentageofcellviabilitywerepresentedasmeans±SD.Statisticalcomparisonsbetweentreatmentgroupsandthecontrolgroupwereperformedusingtheone-wayANOVAfollowedbyposthocTukey(incaseofequalvariance)orDunnett’sT3(incaseofunequalvariance)test.ThesetestswereperformedusingSPSS13forWindows.p<0.05wasconsideredstatisticallysignificant.IC50valuesandtheir95%confidenceinterval(IC95)werecalculatedusingsigmoidaldose-responsemodelwithvariableslopeintheGraphpadPrismsoftware(version4.03).RESULTSANDDISCUSSIONFigure1.AntiproliferativeactivityofDA-Aq,DA-Bu,DA-Ea,DA-Ch,DA-PtandDA-Etonesophagealsquamouscellcarcinoma(Eca-109)cells.Figure2.AntiproliferativeactivityofDA-Aq,DA-Bu,DA-Ea,DA-Ch,DA-PtandDA-Etongastriccarcinoma(AGS)cellsFigure3.AntiproliferativeactivityofDA-Aq,DA-Bu,DA-Ea,DA-Ch,DA-PtandDA-Etonhepatoma(SMMC-7721)cells.Figure4.AntiproliferativeactivityofDA-Aq,DA-Bu,DA-Ea,DA-Ch,DA-PtandDA-Etoncervicalcarcinoma(HeLa)cells.Table1.AntiproliferativeeffectofsixextractsfromthebarksofD.altaicaonfourdifferenttumorcelllines.DataarepresentedasIC50(μg/ml)valuesIndeed,somespeciesofgenusDaphnewerereportedtohavesignificantantitumoractivity.Forexample,itwasdescribedthatextractsandcompoundsofD.genkwa(Zhanetal.,2005),D.mucronata
(Mahdavietal.,2007)andD.odoravar.marginata(Zhangetal.,20
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年度物聯(lián)網(wǎng)應(yīng)用研發(fā)合作合同
- 2024年度汽車行業(yè)人才租賃合同
- 2024年度技術(shù)文獻(xiàn)翻譯合同
- 風(fēng)險(xiǎn)評估模型創(chuàng)新
- 2024年體育場館公共衛(wèi)生間改造工程合同
- 2024年廣告用品訂購合同
- 醫(yī)藥冷庫信息系統(tǒng)集成合同
- 2024年廣場綠化改造合同
- 工廠設(shè)備故障應(yīng)急處置預(yù)案
- 共享辦公室設(shè)計(jì)與施工方案
- 2023年天津公務(wù)員已出天津公務(wù)員考試真題
- 2025年高考數(shù)學(xué)專項(xiàng)題型點(diǎn)撥訓(xùn)練之初等數(shù)論
- 書法知識基礎(chǔ)理論單選題100道及答案解析
- 教科版三年級科學(xué)上冊《第1單元第1課時(shí) 水到哪里去了》教學(xué)課件
- 通信技術(shù)工程師招聘筆試題與參考答案(某世界500強(qiáng)集團(tuán))2024年
- 國際貿(mào)易術(shù)語2020
- (新版)社會工作者考試題庫及答案
- 片石混凝土擋土墻施工方案(改)
- 淺談健美操教學(xué)中的美育教育
- 陜西綠源天燃?xì)庥邢薰咀又轑NG工廠聯(lián)動試車方案
- 青島版小學(xué)科學(xué)六年級上冊25《生物的啟示》教學(xué)設(shè)計(jì)
評論
0/150
提交評論